menu search

IHE / Eli Lilly Beats on Q3 Earnings: ETFs to Buy

Eli Lilly Beats on Q3 Earnings: ETFs to Buy
Eli Lilly (LLY) posted robust third-quarter 2023 earnings results, beating estimates on both the top and bottom lines. Its Mounjaro anti-obesity drug continued its robust performance. Read More
Posted: Nov 3 2023, 12:47
Author Name: Zacks Investment Research
Views: 062313

IHE News  

Eli Lilly Beats on Q3 Earnings: ETFs to Buy

By Zacks Investment Research
November 3, 2023

Eli Lilly Beats on Q3 Earnings: ETFs to Buy

Eli Lilly (LLY) posted robust third-quarter 2023 earnings results, beating estimates on both the top and bottom lines. Its Mounjaro anti-obesity drug more_horizontal

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

By Zacks Investment Research
October 10, 2023

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively more_horizontal

IHE: A Highly Concentrated Portfolio Is Able To Generate Growth Over The Long Run

By Seeking Alpha
August 21, 2023

IHE: A Highly Concentrated Portfolio Is Able To Generate Growth Over The Long Run

iShares U.S. Pharmaceuticals ETF invests almost 80 percent of its assets in its top 10 holdings, and 48.5 percent in just two companies: JNJ and LLY. more_horizontal

Pharma ETF (IHE) Hit a 52-Week High

By Zacks Investment Research
August 15, 2023

Pharma ETF (IHE) Hit a 52-Week High

Investors seeking momentum may have iShares U.S. Pharmaceuticals ETF IHE on radar now. The fund recently hit a new 52-week high. more_horizontal

3 Sector ETFs That Beat The Market Last Week

By Zacks Investment Research
August 14, 2023

3 Sector ETFs That Beat The Market Last Week

Wall Street wrapped up the last week with mixed performances. The pharma and energy sectors were the biggest winners last week. more_horizontal

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

By Zacks Investment Research
August 10, 2023

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively more_horizontal

Eli Lilly Soars on Blockbuster Q2 Earnings: ETFs to Tap

By Zacks Investment Research
August 9, 2023

Eli Lilly Soars on Blockbuster Q2 Earnings: ETFs to Tap

Eli Lilly (LLY) experienced its most significant surge in stock prices in over two decades following the release of an impressive second-quarter 2023 more_horizontal

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

By Zacks Investment Research
May 22, 2023

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Launched on 05/01/2006, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund designed to provide a broad exposure to more_horizontal


Search within

Pages Search Results: